Correlation Between Sinphar Pharmaceutical and CHC Healthcare
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and CHC Healthcare Group, you can compare the effects of market volatilities on Sinphar Pharmaceutical and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and CHC Healthcare.
Diversification Opportunities for Sinphar Pharmaceutical and CHC Healthcare
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sinphar and CHC is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and CHC Healthcare go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and CHC Healthcare
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.72 times more return on investment than CHC Healthcare. However, Sinphar Pharmaceutical Co is 1.4 times less risky than CHC Healthcare. It trades about 0.01 of its potential returns per unit of risk. CHC Healthcare Group is currently generating about 0.0 per unit of risk. If you would invest 3,080 in Sinphar Pharmaceutical Co on August 25, 2024 and sell it today you would earn a total of 35.00 from holding Sinphar Pharmaceutical Co or generate 1.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. CHC Healthcare Group
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| CHC Healthcare Group |
Sinphar Pharmaceutical and CHC Healthcare Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and CHC Healthcare
The main advantage of trading using opposite Sinphar Pharmaceutical and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.| Sinphar Pharmaceutical vs. CHC Healthcare Group | Sinphar Pharmaceutical vs. GenMont Biotech | Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. Wellell |
| CHC Healthcare vs. GenMont Biotech | CHC Healthcare vs. Sinphar Pharmaceutical Co | CHC Healthcare vs. Abnova Taiwan Corp | CHC Healthcare vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |